Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Empowered Funds LLC

Empowered Funds LLC reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 21.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 989 shares of the biotechnology company’s stock after selling 271 shares during the quarter. Empowered Funds LLC’s holdings in Axon Enterprise were worth $395,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in AXON. Blue Trust Inc. increased its holdings in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the period. Quent Capital LLC increased its stake in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the period. Asset Dedication LLC acquired a new position in Axon Enterprise during the 2nd quarter valued at about $47,000. Planning Capital Management Corp raised its position in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares in the last quarter. Finally, Friedenthal Financial acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $51,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Julie A. Cullivan sold 900 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the completion of the sale, the director now owns 3,653 shares of the company’s stock, valued at approximately $1,291,445.09. This trade represents a 19.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 260,256 shares of company stock worth $105,984,120 over the last 90 days. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Robert W. Baird boosted their target price on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Barclays boosted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Craig Hallum raised their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Northland Securities raised their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Trading Up 0.9 %

NASDAQ AXON opened at $636.95 on Monday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $641.20. The firm’s fifty day simple moving average is $463.58 and its 200-day simple moving average is $368.47. The company has a market capitalization of $48.57 billion, a PE ratio of 164.59, a price-to-earnings-growth ratio of 18.89 and a beta of 0.94.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.